These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15966844)

  • 1. Proteomic technologies and their application to pancreatic cancer.
    Vimalachandran D; Costello E
    Expert Rev Proteomics; 2004 Dec; 1(4):493-501. PubMed ID: 15966844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.
    Cui Y; Zhang D; Jia Q; Li T; Zhang W; Han J
    Cancer Invest; 2009 Aug; 27(7):747-55. PubMed ID: 19488907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can proteomic analyses contribute to understanding the molecular biology and clinical behavior of prostate cancer?
    Ware JL
    Expert Rev Proteomics; 2004 Dec; 1(4):485-92. PubMed ID: 15966843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
    Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
    Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics for the identification of new prostate cancer biomarkers.
    Ornstein DK; Tyson DR
    Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of proteomic technologies to discover and identify biomarkers for excessive alcohol consumption: a review.
    Nomura F; Tomonaga T; Sogawa K; Wu D; Ohashi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):35-41. PubMed ID: 17561455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T; Kato H
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
    Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
    Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of the basic proteins in 5-fluorouracil resistance of human colon cancer cell line using the radical-free and highly reducing method of two-dimensional polyacrylamide gel electrophoresis.
    Tanaka S; Sakai A; Kimura K; Yoshida H; Fushitani H; Ogata A; Miyamoto A; Fukushima M; Wada A; Tanigawa N
    Int J Oncol; 2008 Aug; 33(2):361-70. PubMed ID: 18636157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis in human breast cancer: identification of a characteristic protein expression profile of malignant breast epithelium.
    Hudelist G; Singer CF; Pischinger KI; Kaserer K; Manavi M; Kubista E; Czerwenka KF
    Proteomics; 2006 Mar; 6(6):1989-2002. PubMed ID: 16470630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technology insight: the application of proteomics in gastrointestinal disease.
    Din S; Lennon AM; Arnott ID; Hupp T; Satsangi J
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jul; 4(7):372-85. PubMed ID: 17607293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches to proteomic analysis of human tumors.
    Ahram M; Emmert-Buck MR
    Methods Mol Biol; 2003; 222():375-84. PubMed ID: 12710699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
    Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor proteomics: the past, present and future].
    Xu XE; Jiang YH; Shi Q
    Ai Zheng; 2008 Oct; 27(10):1009-17. PubMed ID: 18851778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.